Paine Schwartz invests in Warburton

Paine Schwartz is investing from Paine and Partners Capital Fund IV, which closed on $893m in 2014 and was 74% deployed as of June 2019.

The firm plans to use the company as an animal health and nutrition investment platform. The platform will also include MS Biotech Holdings, in which Paine Schwartz initially invested in October 2018.

William Weldon, who previously worked at Elanco Animal Health, will serve as CEO of the platform company, while Eithna O'Leary will continue as managing director of Warburton. Lourens Havenga will continue to lead Warburton's subsidiary Multimin USA as CEO.

Company
Warburton produces trace-mineral injections for cattle and is the owner and developer of Multimin 90, an injectable solution that provides a supplementary source of zinc, copper, selenium and manganese for cattle.

Founded in 2001 and based in Dublin, the company operates a subsidiary in Colorado, the US, and has also recently launched in the UK and France.

People
Paine Schwartz Partners – Kevin Schwartz (CEO).
Animal health and nutrition platform – William Weldon (CEO).
Warburton Technology – Eithna O'Leary (managing director); Lourens Havenga (CEO, Multimin USA).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• UK / Ireland
• Healthcare
• healthcare
• Ireland
• Buy-and-build
• US